Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.45B 4.03B 514M 443M 420M 380M 714M 49.14B 717M 4.98B 1.92B 25B 1.93B 1.89B 79.01B P/E 2026 *
7.59x
P/E 2027 * 6.74x
Enterprise Value 3.45B 4.03B 514M 443M 420M 380M 714M 49.14B 717M 4.98B 1.92B 25B 1.93B 1.89B 79.01B EV / Sales 2026 *
0.49x
EV / Sales 2027 * 0.46x
Free-Float
45.7%
Yield 2026 *
5.94%
Yield 2027 * 6.68%
08-28 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
08-28 Tong Ren Tang Technologies Co. Ltd. Enters New E-Commerce Service Cooperation Framework Agreement with Beijing Tong Ren Tang Shuzi Technology Co., Ltd CI
07-09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-27 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
1 day+0.32%
1 week-0.32%
Current month+6.60%
1 month-5.26%
3 months-12.01%
6 months-25.00%
Current year-28.57%
1 week 3.09
Extreme 3.09
3.19
1 month 2.96
Extreme 2.955
3.38
Current year 2.96
Extreme 2.955
4.56
1 year 2.96
Extreme 2.955
5.02
3 years 2.96
Extreme 2.955
7.03
5 years 2.96
Extreme 2.955
9.28
10 years 2.96
Extreme 2.955
16
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 37 09/07/2026
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%-0.32%-36.87%-49.92% 513M
+0.71%-0.51%-13.95%-4.41% 13.4B
+0.73%-2.36%-33.00%-56.70% 4.78B
+1.37%-4.28%-4.54%-4.70% 4.36B
+1.25%-3.09%-10.58%-30.50% 3.78B
+0.29%-3.70%-25.45%+1.79% 3.43B
+2.46%-1.28%-1.97%-2.04% 3.41B
-0.07%-4.89%-13.78%+4.32% 3.12B
+1.11%-1.55%-23.77%-16.93% 2.27B
+0.05%-2.76%-29.76%-19.88% 1.63B
Average +0.82%-2.21%-19.37%-17.90% 4.07B
Weighted average by Cap. +0.88%-1.76%-16.29%-13.51%

Financials

2026 *2027 *
Net sales 6.98B 8.16B 1.04B 897M 849M 770M 1.44B 99.43B 1.45B 10.08B 3.88B 50.58B 3.91B 3.82B 160B 7.56B 8.84B 1.13B 971M 920M 834M 1.56B 108B 1.57B 10.92B 4.2B 54.79B 4.23B 4.14B 173B
Net income 454M 531M 67.75M 58.37M 55.27M 50.1M 93.98M 6.47B 94.46M 656M 252M 3.29B 254M 249M 10.4B 514M 600M 76.54M 65.95M 62.44M 56.6M 106M 7.31B 107M 742M 285M 3.72B 287M 281M 11.76B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,801
Date Price Change Volume
14/09/26 HK$3.150 +0.32% 499,000
11/09/26 HK$3.140 -0.16% 1,014,000
10/09/26 HK$3.145 -1.41% 741,000
09/09/26 HK$3.190 +1.27% 1,194,000
08/09/26 HK$3.150 +0.48% 1,330,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.694CNY
Average target price
4.601CNY
Spread / Average Target
+70.76%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!